City

Seoul (1)

Condition

Moderate to Severe Dry Eye (2)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (2)

Sponsor

Alcon Research (1)

Yonsei University (1)

Collaborator

Intervention

cyclosporine 0.1% (ikervis®) eye drop (1)

systane (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

moderate to severe dry eye

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Moderate to Severe Dry Eye Trial in Seoul (Cyclosporine 0.1% (Ikervis®) eye drop)

Recruiting

Moderate to Severe Dry Eye

Cyclosporine 0.1% (Ikervis®) eye drop

Seoul, Korea, Republic of

Severance Hospital

Feb 25, 2021

Moderate to Severe Dry Eye Trial (Systane)

Completed

Moderate to Severe Dry Eye

Systane

(no location specified)

Jan 31, 2012